Skip to search formSkip to main contentSkip to account menu

t(16;16)

A cytogenetic abnormality that involves a translocation occurring within chromosome 16.
National Institutes of Health

Related topics

Related topics

1 relation
Chromosomes, Human, Pair 16

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Slow relapse in acute myeloid leukemia with inv(16) or t(16;16)
Acute myeloid leukemia (AML) with inv(16)(p13q22) or t(16;16)(p13;q22), resulting in CBFβ-MYH11 fusion transcript detectable by… 
2009
2009
Type and Number of Secondary Molecular Lesions Improve Outcome Prediction in Acute Myeloid Leukemia (AML) with inv(16) or t(16;16): A Study of the German-Austrian AML Study Group (AMLSG).
Abstract 824 [][1] Background: Although acute myeloid leukemia (AML) with inv(16)(p13.1q22) or t(16;16)(p13.1;q22) [hereafter… 
2007
2007
Semiquantitative RT-PCR evaluation of the MDR1 gene expression in patients with acute myeloid leukemia.
Resistance to chemotherapy is one of the major obstacles to effective treatment in acute myeloid leukemia (AML). The most… 
2005
2005
Clinical and biological features of favorable-risk acute myelogenous leukemia – is favorable-risk AML really favorable?
Clinical and biological features of favorable-risk acute myelogenous leukemia – is favorable-risk AML really favorable? 
Highly Cited
2000
Highly Cited
2000
Cytogenetically cryptic AML1–ETO and CBFβ–MYH11 gene rearrangements: incidence in 412 cases of acute myeloid leukaemia
The rearrangements t(8;21)(q22;22) and inv(16)(p13q22) are two of the most frequently seen in acute myeloid leukaemia (AML… 
Review
2000
Review
2000
Monosomy 16 as the sole abnormality in myeloid malignancies.
Review
1999
Review
1999
Variant three-way translocation of inversion 16 in AML-M4Eo confirmed by fluorescence in situ hybridization analysis.
1998
1998
Characterization and Use of an Antibody Detecting the CBFβ-SMMHC Fusion Protein in inv(16)/t(16;16)-Associated Acute Myeloid Leukemias
The inv(16)(p13q22) and t(16;16)(p13;q22) cytogenetic abnormalities occur commonly in acute myeloid leukemia (AML), typically… 
1998
1998
Characterization and use of an antibody detecting the CBFbeta-SMMHC fusion protein in inv(16)/t(16;16)-associated acute myeloid leukemias.
The inv(16)(p13q22) and t(16;16)(p13;q22) cytogenetic abnormalities occur commonly in acute myeloid leukemia (AML), typically… 
1994
1994
Karyotypically defined risk groups in acute myeloid leukaemia.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)